Imatinib intermediate is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to signal to each other to grow. They act as chemical messengers. There are a number of different tyrosine kinases and blocking them stops the cancer cells growing.
|Intermediate||CAS No||API/End Use||Status||Purity|
|4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride||106261-49-8||Imatinib||Commercial||99.45%|